The Patent Finder

Healios K.K.

20 patents currently held · Updated Nov 15, 2026
6 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 2 name spellings.

8
Ending by 2030
Jan 2027
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Jan 28, 2027
    The maintenance fee for Methods for Differentiating Cells into Hepatic Stellate Cells and Hepatic Sinusoidal Endothelial Cells, Cells Produced by the Methods, and Methods for Using the Cells (US 9,090,878) comes due Jan 28, 2027. Unpaid by Jul 28, 2027, it lapses early.
  • 1 fee due Sep 5, 2027
    The maintenance fee for Stem Cells for Wound Healing (US 11,918,609) comes due Sep 5, 2027. Unpaid by Mar 6, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 of the patents on this record was granted since Aug 17, 2026
  • 1 term has ended since Aug 17, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 11,992,507MAPC Therapeutics Without Adjunctive Immunosuppressive Treatment
In force
 · High confidence
In forceHigh confidence
US 9,962,407Immunomodulatory Properties of Multipotent Adult Progenitor Cells and Uses Thereof
In force
 · High confidence
In forceHigh confidence
US 8,147,824Immunomodulatory Properties of Multipotent Adult Progenitor Cells and Uses Thereof
In force
 · High confidence
In forceHigh confidence
US 10,226,485Multipotent Adult Stem Cells and Methods for Isolation
In force
 · High confidence
In forceHigh confidence
US D722,994Loudspeaker
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,117,900Mapc Treatment of Brain Injuries and Diseases
In force
 · High confidence
In forceHigh confidence
US 10,253,297Stem Cell Aggregates and Methods for Making and Using
In force
 · Medium confidence
In forceMedium confidence
US 9,005,964Endodermal Progenitor Cells
In force
 · High confidence
In forceHigh confidence
US 10,758,570Modulation of Splenocytes in Cell Therapy
In force
 · High confidence
In forceHigh confidence
US RE51,018Modulation of Splenocytes in Cell Therapy
In force
 · Low confidence
In forceLow confidence
10 of 20 patents shown.
Pro members see all 20.
Pro members: see all 20 patents
Also on record, not counted in the 20: 6 patents in force now held by others · 8 lapsed for an unpaid fee · 9 ended at full term · 1 surrendered on reissue. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

6 pending · 1 abandoned

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited